REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2016 13F Holders as of 6/30/2016

Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
Number of holders
180
Total 13F shares, excl. options
30.4M
Shares change
+713K
Total reported value, excl. options
$832M
Value change
+$19.9M
Put/Call ratio
0.19
Number of buys
95
Number of sells
-67
Price
$27.36

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2016

208 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2016.
REPLIGEN CORP - COMMON STOCK (RGEN) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30.4M shares of 56.2M outstanding shares and own 54.06% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (2.55M shares), OppenheimerFunds, Inc. (1.89M shares), Invesco Ltd. (1.82M shares), VANGUARD GROUP INC (1.57M shares), FMR LLC (1.52M shares), RENAISSANCE TECHNOLOGIES LLC (1.12M shares), Conestoga Capital Advisors, LLC (1.06M shares), DIMENSIONAL FUND ADVISORS LP (1.05M shares), STATE STREET CORP (944K shares), and BlackRock Institutional Trust Company, N.A. (900K shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.